Adjuvant Chemotherapy Using the FOLFOX Regimen in Colon Cancer

机译：FOLFOX方案在结肠癌中的辅助化学疗法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeGreat progress has been made in the adjuvant treatment of colon cancer. The aim of this study was to evaluate the efficacy of postoperative adjuvant chemotherapy using the FOLFOX regimen in patients with stage III and high-risk stage II colon cancer.

机译：目的在结肠癌的辅助治疗方面已取得了很大的进展。这项研究的目的是评估使用FOLFOX方案的术后辅助化疗对III期和高危II期结肠癌患者的疗效。

著录项

期刊名称 Annals of Coloproctology
作者
Hyeong-Joon Jeon; Jin-Hee Woo; Hak-Yoon Lee; Ki-Jae Park; Hong-Jo Choi;
展开▼
作者单位

展开▼
年(卷),期 2011(27),3
年度 2011
页码 140–146
总页数 7
原文格式 PDF
正文语种
中图分类外科学;
关键词
Colonic neoplasms Adjuvant chemotherapy Oxaliplatin FOLFOX protocol;

机译：结肠肿瘤;辅助化疗;奥沙利铂;FOLFOX方案;

相似文献

外文文献
中文文献
专利

1. The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status [J] . Thierry André, Timothy Iveson, Roberto Labianca, Current Colorectal Cancer Reports . 2013,第3期

机译：IDEA（国际辅助化疗持续时间评估）合作：研究III期结肠癌患者用FOLFOX（FOLFOX4或改良的FOLFOX6）或XELOX（3个月和6个月）方案的辅助治疗持续时间的III期试验的前瞻性联合分析：试验设计与现状
2. Comparison of adjuvant FOLFOX4 chemotherapy and oral UFUR/LV following adjuvant FOLFOX4 chemotherapy in patients with stage III colon cancer subsequent to radical resection [J] . Huang Ming-Yii, Huang Chun-Ming, Tsai Hsiang-Lin, Oncology letters . 2017,第6aPta2期

机译：佐剂Folfox4化疗和口服UFUR / LV对辅助FOLFOX4化疗后III阶段结肠癌患者的比较
3. Comparison of adjuvant FOLFOX4 chemotherapy and oral UFUR/LV following adjuvant FOLFOX4 chemotherapy in patients with stage III colon cancer subsequent to radical resection [J] . Huang Ming-Yii, Huang Chun-Ming, Tsai Hsiang-Lin, Oncology letters . 2017,第6aPta3期

机译：佐剂Folfox4化疗和口服UFUR / LV对辅助FOLFOX4化疗后III阶段结肠癌患者的比较
4. Adjuvant Chemotherapy Should Not Routinely Be Recommended to Patients with Stage II Colon Cancers that Manifest Microsatellite Instability [C] . Sigurdis Haraldsdottir, Richard M. Goldberg Gastrointestinal Cancers Symposium . 2014

机译：不应常规向患有阶段结肠癌的患者常规的辅助化学疗法，表明微卫星不稳定性
5. Adherence to adjuvant chemotherapy and post-treatment surveillance in a large community-based cohort of patients with colon cancer. [D] . Hu, Chung-Yuan. 2010

机译：在结肠癌患者的大型社区队列中坚持辅助化疗和治疗后监测。
6. The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status [O] . Thierry André, Timothy Iveson, Roberto Labianca, -1

机译：IDEA（国际辅助化疗持续时间评估）合作：III期试验的前瞻性联合分析研究针对III期结肠癌患者的FOLFOX（FOLFOX4或改良的FOLFOX6）或XELOX（3个月至6个月）方案的辅助治疗的持续时间的III期试验：试验设计与现状
7. The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status [O] . Thierry André, null null, Timothy Iveson, 2013

机译：IDEA（国际辅助化疗持续时间评估）合作：III期试验的前瞻性联合分析，研究针对III期结肠癌患者的FOLFOX（FOLFOX4或改良的FOLFOX6）或XELOX（3个月至6个月）方案的辅助治疗的持续时间的III期试验：试验设计与现状

Adjuvant Chemotherapy Using the FOLFOX Regimen in Colon Cancer

摘要

著录项

相似文献

相关主题

期刊订阅